Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recommendations about transitional coverage of medical devices in France in August 2022

Transitional coverage of medical devices (prise en charge (PEC) transitoire), according to article L165-1-5 of the Social Security, is a newly established pathway to obtain coverage for CE-marked medical devices intended for the treatment of rare or serious diseases or compensation for a disability. The transitional coverage is provided for 12 months with an opportunity for renewal before applying for full-time inclusion in the List of Reimbursable Products and Services (LPPR).

On August 23, 2022, the National Committee for the evaluation of medical devices and health technologies (CNEDiMTS) at the French National Authority for Health (HAS) published a positive opinion for the transitional coverage of the cardiac resynchronization system WISE CRT-SYSTEM by EBR System. The CNEDiMTS considered that the device was eligible for temporary reimbursement in the following indication:

  • In patients with persistent symptomatic heart failure despite optimal drug therapy, who meet current eligibility criteria for cardiac resynchronization therapy (CRT): non-responders to conventional cardiac resynchronization devices, unable to be treated (lead implantation failure or deactivated lead), at a high risk of upgrading;
  • To allow cardiac resynchronization, the system generates endocardial stimulation of the left ventricle synchronized with the stimulation pulse of the right ventricle emitted by an implanted pacemaker or an implanted defibrillator, or an implantable pacemaker with a resynchronization function (CRT-P), or an implantable cardiac defibrillator with resynchronization function (CRT-D).

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).